Vidipha Central Pharmaceutical JSC (HOSE:VDP)

Vietnam flag Vietnam · Delayed Price · Currency is VND
38,100
-2,850 (-6.96%)
At close: Jul 24, 2026
Market Cap841.38B +1.3%
Revenue (ttm)979.05B +3.8%
Net Income62.51B -11.9%
EPSn/a
Shares Out 22.08M
PE Ratio13.46
Forward PEn/a
Dividend2,500.00 (6.11%)
Ex-Dividend Daten/a
Volume210
Open38,100
Previous Close40,950
Day's Range38,100 - 38,100
52-Week Range35,650 - 60,500
Beta-0.18
Analystsn/a
Price Targetn/a
Earnings DateOct 21, 2026

About HOSE:VDP

Vidipha Central Pharmaceutical Joint Stock Company produces and sells pharmaceutical products in Vietnam. It offers analgesics, antipyretics, gastrointestinal agents, antidiabetic agents, antibiotics, antivirals, antifungals, antihistamines, anti-allergic agents, respiratory agents, cardiovascular, neurological, antihypertensive agents, diuretics, vitamins, minerals, antiseptics, and others. The company also engages in the hotel and real estate businesses; and provision of drug storage and testing, and technology transfer consulting services. I... [Read more]

Industry Pharmaceutical Preparations
Founded 2003
Employees 469
Stock Exchange Ho Chi Minh Stock Exchange
Ticker Symbol VDP
Full Company Profile

Financial Performance

In 2025, HOSE:VDP's revenue was 985.64 billion, an increase of 5.47% compared to the previous year's 934.49 billion. Earnings were 63.81 billion, a decrease of -11.16%.

Financial Statements